Document is current

Any future updates will be listed below

HER2-directed therapy improves urothelial cancer outcomes

Crossref DOI link: https://doi.org/10.1038/s41571-025-01089-9

Published Online: 2025-10-27

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark